Global investment giant Ardian has reinvested in Italian pharmaceutical commercialisation business Neopharmed. The post Ardian reinvests in Italian pharma business Neopharmed, NB Renaissance joins as investor first appeared on AltAssets Private Equity News.
Cerea Partners has kicked off deployment of its third fund with the acquisition of a majority stake in France-based Groupe Ethique & Santé, a dietitians network and provider of healthcare services.
European healthcare investor GHO Capital Partners has teamed with Vistria Group to buy a controlling stake in pharma contract development and manufacturing organization Alcami. The post Madison Dearborn, Ampersand sell Alcami stake to GHO Capital,
German healthcare-focused sponsor SHS has sold its minority stake in local endoscopy-tech group Blazejewski Medi-Tech to trade peer Erbe Group.
Private equity investor SEMCAP has launched a new healthcare investing strategy with eyes on a $400m fundraise. The post SEMCAP branches into healthtech with launch of $400m fundraise first appeared on AltAssets Private Equity News.
Corporate advisors expect Triton to launch a sale of UK-headquartered specialty pharma asset Pharmanovia next year, according to three sources familiar with the situation.
JP Morgan Asset Management has launched a new life sciences private equity team targeting early and growth stage healthcare companies. The post JP Morgan AM launches life sciences private equity team first appeared on AltAssets
Consumer-focused private equity major L Catterton has launched an impact investing fund platform targeting companies "making the economy cleaner, healthier, and more equitable". The post L Catterton launches impact investing fund amid ‘revolution in consumer
CVC was considering exit options for Mehiläinen earlier in 2022 but has decided to hold onto the Finnish healthcare group for another few years, according to three sources familiar with the situation.
Lee Equity Partners, a growth oriented middle market private equity firm, has acquired a majority stake in Bradford Health Services. The size of the deal was not disclosed, but Lee Equity has bought the shares
Arizona Public Safety Personnel Retirement System has reportedly invested into Oberland Capital Healthcare III. The post Arizona Public Safety Personnel Retirement System backs Oberland Capital first appeared on AltAssets Private Equity News.
Healthcare-focused private equity firm RC Capital (RCC) has closed a growth and recapitalisation investment in Cognitive Research Corporation, a therapeutically-focused contract research organisation. The post RC Capital recaps investment in Cognitive Research Corporation first appeared
Times might be hard for dealmakers in Europe, the Middle East and Africa (EMEA), but healthcare remains one of the most resilient sectors. And private equity (PE) firms are betting on platform-building as a winning
Houlihan Lokey has poached Rainer Hepberger from William Blair to join its healthcare team in London.
Health investor Digitalis Ventures has hit a $300m final close for its fourth fund. The post Digitalis Ventures targets breakout healthtech with new $300m fund close first appeared on AltAssets Private Equity News.
Chicago-based buyout house Core Industrial Partners has sold pharma packaging and labelling specialist MedLit Solutions to trade buyer Resource Label Group. The post Core Industrial Partners seals rapid MedLit solutions trade sale after just two years
European mid-market buyout investor Stanley Capital Partners has scored a big exit success with the sale of Noden Pharma after just two years in its portfolio. The post Stanley Capital scores 151% IRR on its
The managers of Novalpina 1 have made a major step in the winding down of the liquidated fund by selling crown jewel asset Laboratoire XO to Stanley Capital.
London-based Apposite Capital has hit a £200m final close for its latest fund targeting high growth and high impact healthcare and life science SMEs across Europe. The post Powerful returns see healthcare investor Apposite Capital
Healthcare specialist Apposite Capital has closed its third buyout fund above target on GPB 200m.
